USPTO serial 97977185
BREATHE BIOMEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 26, 2024
- Examiner
- ROACH, APRIL K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BREATHE BIOMEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Moncton, New Brunswick, CA
Moncton, New Brunswick, CA
MONCTON, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Heather Balmat
Heather Balmat BALMAT LAW, PLLC977 SEMINOLE TRAIL, #342CHARLOTTESVILLE, VA 22901United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer hardware and peripheral devices; downloadable computer software and computer programs for use to collect and analyse medical samples; downloadable computer software using machine learning for the analysis of breath spectrograms to identify the presence of disease biomarkers; downloadable computer software using artificial intelligence for use in autonomous decision making; downloadable computer software using artificial intelligence for machine learning of the identification of pathogens and disease biomarkers in the fields of clinical research, health care and health sciences; downloadable computer application software for computing devices, namely, software to control collection of medical samples and to perform analysis of medical samples; downloadable computer software for use to collect and analyse medical samples for use in connection with and as part of medical apparatus and instruments; downloadable clinical software, namely, for use to store and analyse patient medical information data in database systems; downloadable medical diagnostic software; downloadable computer operating system software; calculating machines and data processing equipment; electronic devices for storing, recording, transmitting and reproducing information, data or images, namely, computer hardware and peripheral devices for use in the fields of spectroscopy, collection and analysis of gases, and volatile organic compounds; diagnostic apparatus, not for medical purposes, for use to analyse chemical samples, namely, diagnostic apparatus for the detection of pathogens and disease biomarkers for laboratory or research use; chemical detection systems and apparatus, namely, analysers and testing sampling equipment for use to collect and analyse liquid, solid and gas samples in the nature of sorbent tubes for laboratory use in diagnostic testing, not for medical purposes; gas detectors for detecting the presence of gas, and particle detectors, namely, air quality measurement apparatus in the nature of particle counters; scientific apparatus, namely, spectrometers; temperature sensors, gas sensors for measuring gas concentration, pressure sensors; downloadable computer software for use in medical screening and diagnostics; pharmaceutical and scientific research equipment for use in mass spectrometers; laboratory equipment used for the scientific testing of gases, vapors, and particulate, namely, glass and metal sorbent tubes, in the nature of scientific research specimen collection devices for the purpose of capturing a breath sample | ACTIVE | Nov 15, 2022 |
| 010 | Medical devices, namely, breath gas analyzers for medical diagnostics in the nature of non-invasive devices for breath analysis, point-of-care diagnostic devices for breath analysis, and infrared laser gas analysis devices, all for use to measure volatile compounds in breath and breath gas in the field of medical diagnostics and detection for medical treatment, using non-invasive breath analysis and infrared laser breath gas analysis; diagnostic apparatus for the detection of disease biomarkers, namely, breath gas analyzers for medical diagnostics; medical apparatus, namely, breath gas analysers for medical diagnostics; chemical detection systems and apparatus for medical diagnostic purposes consisting of analysers and sampling equipment for use to collect and analyse liquid, solid and gas samples, namely, breath collection and analysis equipment for testing breath for the presence of disease; medical devices used for the collection, recording, concentration and analysis of volatile organic compounds in human breath, namely, breath gas analyzers for medical diagnostics; medical testing kits for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver, namely, diagnostic kits consisting primarily of thermal desorption tubes for samples for use in medical diagnostic testing; testing apparatus for medical diagnostic purposes, namely, breath detectors being breath gas analyzers for use to detect disease biomarkers; detectors for medical purposes, namely, infrared spectrometers for medical diagnostic use for the detection of pathogens and disease biomarkers; sensors for medical purposes, namely, respiratory sensors | ACTIVE | Jun 27, 2022 |
| 042 | Research services, namely, medical and scientific research services in the field of diagnostics and detection using non-invasive breath analysis and infrared laser gas analysis; scientific and technological services, namely, research and design in the field of computer data storage and interpretation of data; scientific and technological services, namely, scientific consulting in the field of breath research and technical consulting being information technology consultancy, and scientific research, development and design of technology in the field of artificial intelligence and machine learning, and data analysis research being the compilation of data for medical research purposes in the field of artificial intelligence; design and development of machine learning computer software; design and development of computer hardware and software for medical and clinical use; medical research services; clinical research in the field of disease biomarkers; chemical analysis undertaken using a spectrometer to analyse disease biomarkers within gas, liquid and solid samples; chemical research; laboratory analysis in the field of chemistry; biological analysis using a spectrometer to analyse disease biomarkers within gas, liquid and solid samples; scientific laboratory services; scientific and medical laboratory testing services of disease biomarkers within gas, liquid and solid samples; medical research laboratory services; computer programming; product design and development of medical technology and medical apparatus; product research and development services relating to medical apparatus and instruments | ACTIVE | Jun 15, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Picomole Inc.
- Other trademarks owned by Picomole Inc.
- Other trademarks owned by BREATHE BIOMEDICAL INC.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named BREATHE BIOMEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 26, 2024 | NRCS | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 26, 2024 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Feb 20, 2024 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Feb 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 4, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 3, 2024 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 3, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 3, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 1, 2023 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 1, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 6, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 6, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 6, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 4, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 4, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2023 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Jul 5, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 5, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 5, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 5, 2023 | IUAA | USE AMENDMENT ACCEPTED | — |
| Jul 1, 2023 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Jul 1, 2023 | IUAF | USE AMENDMENT FILED | — |
| Jun 30, 2023 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Jun 29, 2023 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jun 29, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2023 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 29, 2023 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| May 11, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 11, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 11, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 20, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2022 | NWAP | NEW APPLICATION ENTERED | — |